Clinical trial
Study of DC Vaccine Loaded Tumor Specific Antigen in Treating Patients With Gastrointestinal Solid Tumor
NCT03185429 is registered in ClinicalTrials.gov with BGI, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of DC Vaccine Loaded Tumor Specific Antigen in Treating Patients With Gastrointestinal Solid Tumor
- Lead sponsor
- BGI, China
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- December 31, 2017
- Completion date
- June 30, 2019
- Enrollment
- 20 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
tumor gastric, tumor, colorectal